Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news



Danone slams NZ High Court for 'undue delay' in Fonterra WPC case

By Mark Astley+


Danone slams NZ High Court for 'undue delay' in Fonterra WPC case

Danone has slammed a New Zealand High Court decision to stall its legal battle to recoup money lost as a result of the Fonterra whey protein concentrate (WPC) botulism scare.

New Zealand High Court judge Justice Geoffrey Venning last week approved Fonterra's request for a temporary stay in the case launched by Danone in January 2014 "to bring all facts to light and to obtain compensation for the harm it has suffered."

Danone claims to have lost sales worth €370m (US$510m, NZ$593m) as a result of the August 2013 WPC botulism alert.

Under the terms of its supply agreement with Fonterra, which Danone terminated in January, arbitration proceedings were simultaneously launched in Singapore.

Approving Fonterra's application for a temporary stay, Venning ordered that the arbitration be completed first.

“Given the substantial degree of factual overlap between the claims in the Singaporean arbitration and these proceedings I consider that it would not be in the interests of justice for both claims to proceed in tandem,” said Venning.

“It is in the interests of cost, convenience and justice that the factual matters be determined first, either in these proceedings or the Singaporean arbitration," the Justice added.

Danone may still pursue its New Zealand High Court if "there are issues not resolved in the arbitration."

"Undue delay"

In a statement sent to, Danone questioned why both cases can't continue concurrently. 

“Danone believes this decision creates undue delay in having its separate High Court claims heard and that there is no reason both matters cannot proceed together," said Danone.

“Danone reiterates that this affair illustrates serious failings throughout the Fonterra group of companies in applying the quality standards required in the food industry. Danone will consult with its legal team to consider next steps in relation to the High Court claim.” approached Fonterra for comment, but no response was forthcoming prior to publication.

Fonterra alerted eight customers, including Danone subsidiaries Nutricia Australia New Zealand (Nutricia ANZ) and Dumex, on August 2 2013 that three batches of WPC potentially contaminated with botulism-causing Clostridium botulinum had entered the supply chain.

Tests later revealed that the bacteria found were Clostridium sporogenes - a non-toxic Clostridium strain.

This information came too late, however, for Nutricia ANZ and Dumex, who, without proof their products were tainted, pulled thousands of units of infant formula from shelves in New Zealand, Cambodia, Thailand, Hong Kong, China, Malaysia, and Singapore.

Fonterra, which vowed previously to "vigorously defend any proceedings", has budgeted for a payout of just NZ$11m (US$9.5m, €7m) to Danone. This figure, Fonterra claims, represents "the maximum contractual liability to Danone."

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars